相关实验视频
Updated: Sep 15, 2025

06:40
The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
6.7K
一个严的游戏"DiaPed":对突尼斯1型糖尿病儿童治疗教育的影响
Sofien Atitallah1,2, Asma Neffati3, Mohamed Amine Boukeri3
1Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia.
Sage open pediatrics
|July 18, 2025
概括
严的游戏DiaPed显著改善了1型糖尿病 (T1D) 的儿童的糖尿病知识. 这种创新的工具显示了治疗性患者教育 (TPE) 在儿科糖尿病管理中的希望.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 医疗教育 技术 技术 医学教育
- 基于游戏的学习
背景情况:
- 儿童的1型糖尿病 (T1D) 需要终身胰岛素治疗和全面的治疗患者教育 (TPE).
- 传统的TPE方法经常被证明是不够的,强调了需要先进的教育工具.
- 严的游戏提供了一种新的方法来增强儿童T1D管理的TPE.
研究的目的:
- 评估严重游戏DiaPed在提高被诊断为1型糖尿病的儿童知识方面的有效性.
- 评估DiaPed对理解T1D,胰岛素治疗和低血糖管理的影响.
主要方法:
- 采用了前后干预研究设计.
- 40名患有T1D的儿童参加了突尼斯的一家儿科糖尿病诊所的研究.
- 参与者参与了严的游戏DiaPed,专注于T1D教育.
主要成果:
- 在游戏后观察到知识分数的统计学上显著增加 (29.8±6.02至68.6±1.58,P<.001).
- 一个大的效果大小 (科恩指数 = 6.72) 表明对知识获取有实质性的影响.
- 在满意度调查中报告了参与者的高参与度和热情.
结论:
- 严的游戏DiaPed在患有T1D的儿童中对与糖尿病相关的知识产生了显著的积极影响.
- 迪亚佩德 (DiaPed) 提供了一种有价值和引人入胜的工具,用于提高儿童糖尿病护理中的治疗患者教育.
- 严的游戏具有潜力,可以作为慢性儿科疾病的传统TPE策略的有效补充.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Insulin: Dosing Regimen and Adverse Effects
262
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
262

